- Home
- ARVN vs WNC Comparison
ARVN vs WNC Comparison
Compare ARVN & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- WNC
- Stock Information
- Founded
- ARVN 2015
- WNC 1985
- Country
- ARVN United States
- WNC United States
- Employees
- ARVN N/A
- WNC N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- WNC Construction/Ag Equipment/Trucks
- Sector
- ARVN Health Care
- WNC Industrials
- Exchange
- ARVN Nasdaq
- WNC Nasdaq
- Market Cap
- ARVN 456.2M
- WNC 425.6M
- IPO Year
- ARVN 2018
- WNC 1991
- Fundamental
- Price
- ARVN $7.53
- WNC $9.37
- Analyst Decision
- ARVN Buy
- WNC Hold
- Analyst Count
- ARVN 21
- WNC 1
- Target Price
- ARVN $20.53
- WNC $14.00
- AVG Volume (30 Days)
- ARVN 2.2M
- WNC 587.0K
- Earning Date
- ARVN 07-29-2025
- WNC 07-23-2025
- Dividend Yield
- ARVN N/A
- WNC 3.40%
- EPS Growth
- ARVN N/A
- WNC N/A
- EPS
- ARVN N/A
- WNC N/A
- Revenue
- ARVN $426,900,000.00
- WNC $1,812,354,000.00
- Revenue This Year
- ARVN $2.83
- WNC N/A
- Revenue Next Year
- ARVN N/A
- WNC $18.83
- P/E Ratio
- ARVN N/A
- WNC N/A
- Revenue Growth
- ARVN 498.74
- WNC N/A
- 52 Week Low
- ARVN $5.90
- WNC $6.78
- 52 Week High
- ARVN $34.11
- WNC $24.03
- Technical
- Relative Strength Index (RSI)
- ARVN 54.38
- WNC 52.83
- Support Level
- ARVN $6.70
- WNC $8.91
- Resistance Level
- ARVN $7.60
- WNC $9.28
- Average True Range (ATR)
- ARVN 0.45
- WNC 0.39
- MACD
- ARVN 0.15
- WNC 0.07
- Stochastic Oscillator
- ARVN 95.04
- WNC 67.36
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The company's mission is to enable customers to succeed with breakthrough ideas and solutions that help them move everything from the first to the final mile. It designs and manufactures a diverse variety of products, including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.